Home › Funds › HSG Holding Ltd › GPCR
HSG Holding Ltd position in GPCR
STRUCTURE THERAPEUTICS INC · Health Care
HSG Holding Ltd reported holding 266,062 shares of GPCR (STRUCTURE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$8.3M, representing 0.66% of its reported portfolio and ranking #11 among its reported holdings. HSG Holding Ltd has disclosed GPCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How HSG Holding Ltd's GPCR position evolved
HSG Holding Ltd first disclosed a stake in GPCR in Q3 2023 at 1,065,226 shares (US$53.7M). Across 13 filings, HSG Holding Ltd increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 266,062 shares valued at US$8.3M. Notable position changes include a 75% trim in Q2 2024 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.07M | $53.71M | New |
| Q4 2023 | 1.07M | $44.10M | Hold |
| Q1 2024 | 1.06M | $38.44M | Hold |
| Q2 2024 | 266.06K | $10.28M | Reduce |
| Q3 2024 | 266.06K | $10.33M | Hold |
| Q4 2024 | 266.06K | $7.54M | Hold |
| Q1 2025 | 266.06K | $6.20M | Hold |
| Q2 2025 | 266.06K | $5.52M | Hold |
| Q3 2025 | 266.06K | $4.61M | Hold |
| Q4 2025 | 266.06K | $24.44M | Hold |
| Q1 2026 | 266.06K | $6.20M | Hold |
| Q2 2026 | 266.06K | $14.28M | Hold |
| Q3 2026 | 266.06K | $8.32M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GPCR and 13F data
GPCR (STRUCTURE THERAPEUTICS INC) is a Health Care company. 29 other funds we track also report a position in GPCR — the largest reported positions include Avoro Capital Advisors LLC (US$351.8M), Deep Track Capital, LP (US$254.4M), BVF INC/IL (US$180.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GPCR
- Avoro Capital Advisors LLC 6.56M sh · $351.84M · Q2 2026
- Deep Track Capital, LP 4.74M sh · $254.40M · Q2 2026
- BVF INC/IL 3.37M sh · $180.70M · Q2 2026
- ORBIMED ADVISORS LLC 2.21M sh · $118.58M · Q2 2026
- RTW INVESTMENTS, LP 1.61M sh · $86.27M · Q2 2026
- BAKER BROS. ADVISORS LP 1.43M sh · $76.88M · Q2 2026
- Casdin Capital 1.18M sh · $63.06M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.09M sh · $58.29M · Q2 2026
- Rock Springs Capital Management LP 640.32K sh · $34.37M · Q2 2026
- Siren, L.L.C. 872.97K sh · $27.30M · Q3 2026
- Logos Global Management LP 500.00K sh · $26.84M · Q2 2026
- Parkman Healthcare Partners LLC 485.66K sh · $26.07M · Q2 2026
More on HSG Holding Ltd
FAQ
How long has HSG Holding Ltd held GPCR?
HSG Holding Ltd has disclosed GPCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is HSG Holding Ltd's current position in GPCR?
As of Q3 2026, HSG Holding Ltd holds 266.06K shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $8.32M, representing 0.66% of its reported portfolio and ranking #11.
Has HSG Holding Ltd been buying or selling GPCR?
In the latest 13F filing (Q3 2026), HSG Holding Ltd held unchanged its position in GPCR.
Which other funds hold GPCR?
Other major institutional holders of GPCR include Avoro Capital Advisors LLC, Deep Track Capital, LP, BVF INC/IL, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.